Mark Hunter

2.0k total citations
28 papers, 1.0k citations indexed

About

Mark Hunter is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology. According to data from OpenAlex, Mark Hunter has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 11 papers in Reproductive Medicine and 7 papers in Immunology. Recurrent topics in Mark Hunter's work include Endometrial and Cervical Cancer Treatments (10 papers), GDF15 and Related Biomarkers (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). Mark Hunter is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), GDF15 and Related Biomarkers (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). Mark Hunter collaborates with scholars based in United States, Australia and South Korea. Mark Hunter's co-authors include Samuel N. Breit, David A. Brown, Asne R. Bauskin, Bradley J. Monk, Krishnansu S. Tewari, Támara Kuffner, Heiko Johnen, Xiaohe Luo, C. Nicole Rosenzweig and Zhen Zhang and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Mark Hunter

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hunter United States 14 520 356 348 294 233 28 1.0k
Enrico Farnetti Italy 19 370 0.7× 64 0.2× 272 0.8× 123 0.4× 233 1.0× 63 1.0k
Linda N. Dao United States 10 56 0.1× 145 0.4× 69 0.2× 251 0.9× 208 0.9× 29 723
Wei Xie United States 17 60 0.1× 98 0.3× 259 0.7× 220 0.7× 370 1.6× 55 986
A. Jayne Crew United Kingdom 11 219 0.4× 33 0.1× 151 0.4× 462 1.6× 620 2.7× 11 1.4k
Ulrich Freudensprung Switzerland 11 84 0.2× 37 0.1× 290 0.8× 350 1.2× 124 0.5× 43 898
Odilia B. J. Corneth Netherlands 22 286 0.6× 332 0.9× 797 2.3× 238 0.8× 244 1.0× 46 1.5k
Najat Mourra France 23 85 0.2× 30 0.1× 44 0.1× 609 2.1× 293 1.3× 79 1.5k
Herman Van den Berghe Belgium 10 63 0.1× 57 0.2× 42 0.1× 71 0.2× 302 1.3× 12 708
Markus Tiemann Germany 17 50 0.1× 61 0.2× 248 0.7× 407 1.4× 177 0.8× 73 959

Countries citing papers authored by Mark Hunter

Since Specialization
Citations

This map shows the geographic impact of Mark Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hunter more than expected).

Fields of papers citing papers by Mark Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hunter. The network helps show where Mark Hunter may publish in the future.

Co-authorship network of co-authors of Mark Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hunter. A scholar is included among the top collaborators of Mark Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hunter. Mark Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Jiude, Ryan M. Marquardt, San‐Pin Wu, et al.. (2025). Progesterone signaling in oviductal epithelial cells modulates the immune response to support preimplantation embryonic development. Science Advances. 11(16). eadt6113–eadt6113. 1 indexed citations
2.
Tran, Dinh Nam, Lyndon M. Coghill, Mark Hunter, et al.. (2024). ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer. Reproductive Sciences. 31(6). 1632–1641. 4 indexed citations
3.
Hunter, Mark, et al.. (2024). Hormonal regulation of cilia in the female reproductive tract. Current Opinion in Endocrine and Metabolic Research. 34. 100503–100503. 6 indexed citations
4.
5.
Hunter, Mark, et al.. (2023). Reversible female contraceptives: historical, current, and future perspectives. Biology of Reproduction. 110(1). 14–32. 2 indexed citations
6.
Kim, Tae Hoon, Na-Young Bae, Taeho Kim, et al.. (2022). Leptin Stimulates Endometriosis Development in Mouse Models. Biomedicines. 10(9). 2160–2160. 13 indexed citations
7.
Broaddus, Russell R., et al.. (2022). MIG-6 Is Critical for Progesterone Responsiveness in Human Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer. International Journal of Molecular Sciences. 23(23). 14596–14596. 3 indexed citations
8.
Hunter, Mark, et al.. (2019). Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer. Journal of Minimally Invasive Gynecology. 26(5). 968–972. 12 indexed citations
9.
Bender, David, Michael W. Sill, Heather A. Lankes, et al.. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 138(3). 507–512. 48 indexed citations
10.
Bender, David, Michael W. Sill, Heather A. Lankes, et al.. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. PMC. 14 indexed citations
11.
Smith, Gareth Dylan, et al.. (2015). Understanding small music venues: a report by the Music Venue Trust. Middlesex University Research Repository (Middlesex University Of London). 2 indexed citations
12.
Skipworth, Richard J.E., D A C Deans, Benjamin Tan, et al.. (2010). Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. British Journal of Cancer. 102(4). 665–672. 38 indexed citations
13.
Mahdavi, Ali, et al.. (2009). Pelvic Radiation Improves Local Control After Hysterectomy for Uterine Leiomyosarcoma. International Journal of Gynecological Cancer. 19(6). 1080–1084. 25 indexed citations
14.
Hunter, Mark, Krishnansu S. Tewari, & Bradley J. Monk. (2008). Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease. American Journal of Obstetrics and Gynecology. 199(1). 10–18. 48 indexed citations
15.
Hunter, Mark, Bradley J. Monk, & Krishnansu S. Tewari. (2008). Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. American Journal of Obstetrics and Gynecology. 199(1). 3–9. 60 indexed citations
16.
Hunter, Mark, et al.. (2007). Epithelial Ovarian Cancer and Low Malignant Potential (LMP) Tumors Associated With a Lower Incidence of Second Primary Breast Cancer. American Journal of Clinical Oncology. 30(1). 1–7. 7 indexed citations
17.
Lonky, Neal M., et al.. (2007). Cost-Effectiveness of Adding Human Papilloma Virus Testing to a Managed Care Cervical Cancer Screening Program. Journal of Lower Genital Tract Disease. 11(4). 258–264. 1 indexed citations
18.
Tewari, Devansu, et al.. (2004). Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma. Investigational New Drugs. 22(4). 475–480. 20 indexed citations
19.
Hunter, Mark. (1997). Le journalisme d'investigation : aux États-Unis et en France. Presses Universitaires de France eBooks. 1 indexed citations
20.
Smyth, Emer M., et al.. (1978). Lord Mayor Treloar Hospital, Alton. BMJ. 2(6134). 436.2–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Farnetti Breakdown of academic impact, for papers by Linda N. Dao Breakdown of academic impact, for papers by Wei Xie Breakdown of academic impact, for papers by A. Jayne Crew Breakdown of academic impact, for papers by Ulrich Freudensprung Breakdown of academic impact, for papers by Odilia B. J. Corneth Breakdown of academic impact, for papers by Najat Mourra Breakdown of academic impact, for papers by Herman Van den Berghe Breakdown of academic impact, for papers by Markus Tiemann
Rankless by CCL
2026